Oxford Biomedical Research, Inc. Awarded USDA Grant to Develop Tests for the Quality of Animal Feeds
July 27, 2021
ROCHESTER HILLS, Mich. -- Oxford Biomedical Research, Inc., a privately held biotechnology company, has been awarded a $99,203 Phase I Small Business Innovation Research Grant by the National Institute of Food and Agriculture [NIFA, award #2021-33530-34397]. This grant, entitled "SIMPLE & RAPID TESTS FOR THE QUALITY OF ANIMAL FEEDS" will support the development of rapid tests to evaluate the [...]
July 27, 2021
EverBrite® Mounting Media now offers options with far-red nuclear-specific NucSpot® 640 as well as TrueBlack® Lipofuscin Autofluorescence Quencher. Caption: Human cerebral cortex cryosections were stained with CF®405S GFAP Antibody (glial cells, cyan), then mounted with EverBrite™ Hardset with NucSpot® 640, or EverBrite TrueBlack® Hardset with NucSpot® 640. Lipofuscin autofluorescence appears orange in the merged image [...]
CN Bio licenses human gut microbiome modelling tool from MIT and Northeastern University
July 27, 2021
Enables accurate modelling of the human colon and the mucosal barrier Provides new insights to the relationship between human microbiome and effect on human health Model to be integrated into CN Bio’s PhysioMimix™ OOC range of single- and multi-organ microphysiological systems Cambridge, UK: CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single- and multi-organ [...]
July 27, 2021
Covalent Metrology installs new Thermo Scientific iCAP TQ for inductively coupled plasma mass spectrometry (ICP-MS) and announces Nanette Jarenwattananon, PhD will lead its analytical chemistry team. Sunnyvale, CA. Covalent Metrology, a leading North American provider of analytical services, announces an expansion of its chemical analysis capabilities with the install of a Thermo Scientific iCAP TQ for inductively [...]
BioFlyte Forms Scientific Advisory Board of Prominent Government and Life Science Experts
July 27, 2021
ALBUQUERQUE, N.M.– BioFlyte, a biodetection company with a revolutionary new class of fieldable biological threat collection, detection, and identification solutions, today announced the formation of a Scientific Advisory Board (SAB). The SAB is comprised of seven accomplished industry leaders who will guide development and commercialization efforts for BioFlyte’s field-deployable precision biological mass spectrometry solutions for [...]
July 27, 2021
BILLERICA, Massachusetts – Bruker today launched the latest version of its NMR Honey-Profiling™ module for the advanced detection of the ever evolving modes of honey adulteration. The new module expands the growing database to 28,000 reference honey samples, covering over 50 countries, 100 monofloral varieties and many polyfloral varieties. It allows honey producers and distributors [...]
July 27, 2021
Major investments are expanding manufacturing capacity for life sciences products at 13 Cytiva and Pall Corporation sites helping to meet customer demand. New sites opening in US and UK to realize regional manufacturing models. Overall, the companies plan to hire 2000 full-time associates over the next two years. Investment follows five strategic acquisitions made by [...]
Biosimilar Products for Research Use
July 27, 2021
AMSBIO has launched a new range of research grade biosimilars that enable analysis of biological processes without the need to purchase expensive therapeutic-grade biologics. Investigating the biological effects of a drug or doing proof of concept assay development, requires a source of the drug. Typically, it is difficult to obtain original pharmaceutical grade biotherapeutic drugs for research use, [...]
July 27, 2021
Strengthening Bio-Techne's leadership in the spatial genomics market with significant expansion of the ACD RNAscope HiPlex platform capabilities MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH) today announced the expansion of the Advanced Cell Diagnostics (ACD), a Bio-Techne brand, RNAscope in situ hybridization technology portfolio with the release of new RNAscope HiPlex V2 assay for formalin-fixed paraffin-embedded (FFPE) [...]
10x Genomics Signs Global Patent Cross License Agreement with Bio-Rad
July 27, 2021
Agreement to Cross License Single Cell Technologies Ends all Ongoing Legal Disputes PLEASANTON, Calif. -- 10x Genomics, Inc. (Nasdaq: TXG) today announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb). The agreement resolves all outstanding litigation and other proceedings between the two companies across [...]

